LANTZ, Steven Andrew,GUPTA, Kapil,SULE, Shantanu,ZUNIC, Adnan
申请号：
AU2018321335
公开号：
AU2018321335A1
申请日:
2018.08.22
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Pharmaceutical compositions containing anti-beta amyloid (Aβ) antibodies or Aβ-binding fragments thereof are provided. These pharmaceutical compositions find use in the treatment of abnormal accumulation or deposition of Aβ in the central nervous system, mild cognitive impairment, and Aβ-associated disorders such as Alzheimer's disease.
